- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07638514
Postoperative Analgesia Using a Perineural Catheter Versus a Single Nerve Block in Rearfoot Surgery (CATHORNOT)
A Comparative Evaluation of Postoperative Analgesia Using a Perineural Catheter Versus a Single Nerve Block in Rearfoot Surgery
Postoperative pain following hindfoot surgery is often severe and can persist for several days. It frequently leads to the use of systemic analgesics, particularly opioids, whose adverse effects are well known. Furthermore, poorly controlled postoperative pain is a recognized independent risk factor for the development of chronic pain.
Ambulatory perineural catheter techniques, already used in our department for hindfoot surgeries, allow for continuous infusion of local anesthetic. They have demonstrated their efficacy in numerous orthopedic surgeries, but data specific to hindfoot surgery remain limited. It therefore seems appropriate to evaluate whether prolonged analgesia via a perineural catheter improves postoperative pain management and promotes functional recovery.
The study is conducted as a practice evaluation audit. It relies on the collection of data from routine care, without any modification to intraoperative care. This methodology allows for an objective evaluation of the benefits of the perineural catheter compared to a single-injection popliteal sciatic block with local anesthetic, while documenting the frequency and nature of complications associated with the technique (leaks, accidental or intentional catheter removal).
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Geschätzt)
Kontakte und Standorte
Studienkontakt
- Name: Benjamin DUMARTINET
- Telefonnummer: +33 241353637
- E-Mail: benjamin.dumartinet@chu-angers.fr
Studienorte
-
-
-
Angers, Frankreich
- University Hospital of Angers
-
Kontakt:
- Benjamin DUMARTINET
- Telefonnummer: +33 241353637
- E-Mail: benjamin.dumartinet@chu-angers.fr
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- Adult patients;
- Patients with an American Society of Anesthesiologists physical status (ASA score) of 1, 2, or 3;
- Patients who have undergone hindfoot surgery;
- Patients capable of completing the questionnaires.
Exclusion Criteria:
- Contraindications to regional anesthesia (known hypersensitivity to the local anesthetic, infection at the injection site, uncontrolled neurological condition);
- Emergency surgery
- Cognitive impairment;
- Uncontrolled psychiatric condition;
- Pregnancy or breastfeeding;
- Substance abuse;
- Use of neuroleptics or lithium;
- Individuals subject to legal guardianship
- Individuals deprived of liberty by judicial or administrative order
- Patients who object to the study.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
Regionalanästhesie
|
All patients are contacted by phone to assess pain during movement and at rest on each of the first 3 days after surgery, as well as their use of various pain medications
|
|
ambulatory perineural catheter
|
All patients are contacted by phone to assess pain during movement and at rest on each of the first 3 days after surgery, as well as their use of various pain medications
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Pain on movement using a numerical scale from 0 to 11
Zeitfenster: Day 1 postoperative
|
to compare the efficacy of an ambulatory perineural catheter for prolonging analgesia and reducing postoperative pain following hindfoot surgery, compared with single-shot regional anesthesia
|
Day 1 postoperative
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
postoperative pain at rest using a numerical scale from 0 to 11
Zeitfenster: From Baseline to Day 3
|
to assess analgesic efficacy at rest
|
From Baseline to Day 3
|
|
postoperative pain during mobilization using a numerical scale from 0 to 11
Zeitfenster: From Baseline to Day 3
|
to evaluate the analgesic efficacy during mobilization
|
From Baseline to Day 3
|
|
Postoperative consumption of morphine equivalents in milligrams
Zeitfenster: From Baseline to Day 3
|
Cumulative
|
From Baseline to Day 3
|
|
Daily postoperative consumption of morphine equivalents in milligrams
Zeitfenster: Baseline, Day 1, Day 2 and Day 3
|
Daily
|
Baseline, Day 1, Day 2 and Day 3
|
|
Postoperative use of non-opioid analgesics
Zeitfenster: From Baseline to Day 3
|
Cumulative
|
From Baseline to Day 3
|
|
Daily postoperative use of non-opioid analgesics
Zeitfenster: Baseline, Day 1, Day 2 and Day 3
|
Daily
|
Baseline, Day 1, Day 2 and Day 3
|
|
French Quality of Recovery -15 score (FQoR-15 - from 0 to 150)
Zeitfenster: Baseline and day 2
|
to assess functional recovery and postoperative rehabilitation
|
Baseline and day 2
|
|
number of complications
Zeitfenster: From baseline to day 3
|
Accidental or intentional removal of the catheter Leaks at the injection site or in the infusion system Bruise or local infection Crashes potentially related to the residual engine block
|
From baseline to day 3
|
|
proportion of patients experiencing at least one postoperative complication following hindfoot surgery
Zeitfenster: From baseline to Day 3
|
Readmission to the hospital Consultation with the attending physician for uncontrolled postoperative pain or complications related to the procedure Confirmed infection with antibiotic treatment initiated
|
From baseline to Day 3
|
|
length of hospital stay, calculated in whole days
Zeitfenster: From Baseline to Day 3
|
Duration censored on Day 3 if the patient is still hospitalized on that date
|
From Baseline to Day 3
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Benjamin DUMARTINET, University Hospital of Angers
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 49RC26_0116
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Phone contact
-
Central Hospital, Nancy, FranceAbgeschlossenSelbstmord und SelbstverletzungFrankreich
-
nthalmic Pty LtdRekrutierungKurzsichtigkeit | Fortschreiten der KurzsichtigkeitChina, Malaysia
-
L.V.A. BoersmaAbgeschlossen
-
Massachusetts Eye and Ear InfirmaryM.D. Anderson Cancer Center; Wills EyeBeendetNävus | Rassen Melanose | Primär erworbene Melanose | Malignes Melanom der BindehautVereinigte Staaten
-
Abbott Medical DevicesAbgeschlossenTypisches VorhofflatternVereinigte Staaten, Kanada
-
Elixir Medical CorporationAbgeschlossen
-
DePuy InternationalAbgeschlossenArthroplastik, Ersatz, KnieIrland
-
University of MiamiAbgeschlossenDiabetischer Fuß | FußgeschwürVereinigte Staaten
-
The Hong Kong Polytechnic UniversityAbgeschlossen
-
Bausch & Lomb IncorporatedAbgeschlossenMyopie und Hyperopie und PresbyopieVereinigte Staaten